{"id":"W4392799091","doi":"10.2139/ssrn.4750763","title":"A Phase Ii, Open-Label, Randomized Trial of Durvalumab with Olaparib or Cediranib in Patients with Mismatch Repair–Proficient Colorectal or Pancreatic Cancer","year":2024,"lang":"en","type":"preprint","venue":"SSRN Electronic Journal","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ontario Institute for Cancer Research; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Olaparib; Durvalumab; Medicine; Colorectal cancer; Oncology; Internal medicine; Randomized controlled trial; Open label; Pancreatic cancer; Cancer; Nivolumab; Chemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001612975,0.002076411,0.003071313,0.0003480261,0.000404716,0.001348023,0.0008684187,0.001498641,0.009342173],"category_scores_gemma":[0.001749845,0.0007300614,0.001821614,0.0003802624,0.001258111,0.00144292,0.0004673144,0.004043267,0.001532112],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009835163,"about_ca_system_score_gemma":0.001305098,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00100945,"about_ca_topic_score_gemma":0.002253365,"domain_scores_codex":[0.9994214,0.0003075699,0.00002468441,0.0001209748,0.00003183339,0.00009360067],"domain_scores_gemma":[0.9991189,0.0002550648,0.0001424348,0.00008921848,0.00004286677,0.0003515576],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9787088,0.005286196,0.000381006,0.0002728529,0.000780327,0.00003300951,0.00003099218,0.0003622682,0.001671446,0.0001468312,0.00100699,0.01131941],"study_design_scores_gemma":[0.9703512,0.02775994,0.0005232485,0.00001159154,0.000209815,0.00002243497,0.00001615448,0.0002648554,0.0001683374,0.0001478145,0.0005156656,0.000008965088],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9802213,0.005052121,0.001298194,0.001753304,0.001128755,0.004130795,0.002389867,0.0001741397,0.003851549],"genre_scores_gemma":[0.9756262,0.003534704,0.003326826,0.002425412,0.0006164662,0.004924609,0.003044987,0.00006154622,0.006439249],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009342173,"threshold_uncertainty_score":0.03125262,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02572396778277128,"score_gpt":0.3491605832684948,"score_spread":0.3234366154857236,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}